Search Results 151-160 of 16713 for pv

  1. Imetelstat Sodium in Treating Patients with Primary or Secondary Myelofibrosis - Mayo Clinic

    Post-ET/PV MF per the IWG-MRT criteria. High-risk or Intermediate-2 risk MF (as defined by the Dynamic International Prognostic Scoring System [DIPSS-plus]) ...

  2. Correlative Biomarker Study in Patients With Myeloproliferative Disorders - Mayo Clinic

    Patients diagnosed with the following Myeloproliferative disorders including: polycythemia vera (PV), idiopathic myelofibrosis (IM), and essential ...

  3. Publications - Dimitar K. Gavrilov, M.D., Ph.D. - Mayo Clinic

    ... PV, de Sain-Van der Velden MG, Elvers B, Morrissey MA, Sunny S, Knoll D, Webster D, Frazier DM, McClure JD, Sesser DE, Willis SA, Rocha H, Vilarinho L, John ...

  4. A Study to Establish a Research Tissue Bank for Myeloproliferative Neoplasms - Mayo Clinic

    Newly diagnosed subjects diagnosed with Philadelphia chromosome negative myeloproliferative neoplasms (MPN) polycythemia vera (PV), prefibrotic ...

  5. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    ... PV MF), or Post-essential Thrombocythemia Myelofibrosis (post-ET MF). Study of LY2784544 Testing Alternative Dosing in Participants with Myeloproliferative ...

  6. Ruxolitinib Prior to Transplant in Patients With Myelofibrosis - Mayo Clinic

    Documented diagnosis of primary myelofibrosis according to WHO criteria or post PV myelofibrosis or post ET myelofibrosis as per IWG-MRT criteria; Age 18-70 ...

  7. Publications - Arturo M. Valverde, M.D. - Mayo Clinic

    ... PV, Ahmad ST, Ahmed ZM, Ahumada-Castro U, Aits S, Aizawa S, Akkoc Y, Akoumianaki T, Akpinar HA, Al-Abd AM, Al-Akra L, Al-Gharaibeh A, Alaoui-Jamali MA ...

  8. Quality of Life and Symptomatic Response in Myelofibrosis Patients Receiving an Allogeneic Stem Cell Transplant - Mayo Clinic

    Participation eligibility · All patients must have myelofibrosis (MF) including primary MF, Post-ET, or Post–PV MF. · Patients must be planning to undergo ...

  9. Study of TL-895 in Subjects With Myelofibrosis - Mayo Clinic

    * Adults ≥18 years of age * Confirmed diagnosis of PMF, post-PV MF, or post-ET MF, as assessed by treating physician according to the World Health ...

  10. Publications - Joaquin J. Garcia, M.D. - Mayo Clinic

    Viscuse PV, Price KA, Garcia JJ, Schembri-Wismayer DJ, Chintakuntlawar AV. First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With ...